Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?
Timothy D. Henry, Daniel Satran, Lorri L. Knox, Cheryl L. Iacarella, David D. Laxson, Elliott M. AntmanVolume:
142
Year:
2001
Language:
english
DOI:
10.1067/mhj.2001.117317
File:
PDF, 119 KB
english, 2001